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Background: The Venous Clinical Severity Score (VCSS) and the
Aberdeen Varicose Vein Questionnaire (AVVQ) are both dynamic assess-
ment tools which measure the effects of venous treatment in patients with
Superficial Venous Insufficiency (SVI). The total scores universally improve
after treatment but it is unclear which questions are the most responsive to
change and which questions remain relatively static. The aim of this study
was to evaluate the change in each question following treatment at 3 weeks
and 3 months.
Methods: This is a retrospective study on a database of 100 patients
(M:F41:59) with SVI (C234,C314,C4a29,C4b9,C57,C67)
who received treatment with endovenous laser ablation (n50) or foam
sclerotherapy (n50). The change scores of each question of the VCSS
(questions 1-10) and the AVVQ (questions 1-13) were calculated by sub-
tracting the score at 3 weeks, and 3 months, from the pretreatment score.
Significant changes (P.05) were highlighted using the Wilcoxon test. A
subgroup analysis was also performed (n92) on treatment type. Patients
were also stratified at 3 months using complete abolition of saphenous reflux
with normalization of the Venous Filling Index (VFI2.5ml/sec) on air
plethysmography (n38, Group A) versus any remaining haemodynamic
impairment on duplex or VFI (n54, Group B).
Results: Both the median (IQR) VCSS and the AVVQ scores signifi-
cantly improved. From 6(4) and 21.4(15.1) at baseline to 3(4) and
18.6(12.1) at 3 weeks (P.0005, P.031) and to 2(3) and 8.8(13.6)
respectively at 3 months, (P.0005, P.0005). The first 3 questions of the
VCSS (pain, extent of varicosities, edema) responded most to the effects of
treatment, in all categories, Table I. Questions 5,6,7,9 on inflammation and
active ulceration all improved individually but responded least overall due to
statistical dilution (7/100 patients). The majority of the AVVQ questions
on quality of life significantly improved, Table II. However, VCSS Q.10 and
AVVQ Q.5 were not useful (negative change) because stocking application
was recommended early posttreatment identifying greater severity.
Table I. Individual VCSS questions and the significance of their change.
*deterioration
VCSS P  .05
P  .05 &
P  .0005 P  .0005
Total 3 weeks 5,6 7,8,9,10* 1,2,3,4
Total 3 months 6,7,9 4,5,8,10 1,2,3
Laser 3 weeks 5,6,7,8,9 4 1,2,3,10*
Foam 3 weeks 5,6,7,8,9,10 4 1,2,3
Laser 3 months 5,6,7,8,9,10 4 1,2,3
Foam 3 months 4,5,6,7,8,9 10 1,2,3
Group A 4,5,6,7,8,9,10 — 1,2,3
Group B 5,6,7,8,9 10,4 1,2,3
Table II. Individual AVVQ questions and the significance of their change.
*deterioration
AVVQ P  .05
P  .05 &
P  .0005 P  .0005
Total 3 weeks 9,12,13 2,3,6,11 1,4,5*,7,8,10
Total 3 months 5,9 3 1,2,4,6,7,8,10,11,
12,13
Laser 3 weeks 2,9,12,13 4,6,8,11 1,3,5*,7,10
Foam 3 weeks 3,6,9,11,13 2,7,8,10,12 1,4,5*
Laser 3 months 3,5 8,9,11,12 1,2,4,6,7,10,13
Foam 3 months 3,5,9 6,7,8 1,2,10,11,12,13
Group A 3,5,9 7,8 1,2,4,6,10,11,12,13
Group B 5,9 3,7,8,12 1,2,4,6,10,11,13
Conclusions: The individual questions of the VCSS and AVVQ are
significantly responsive to change following treatment at 3 weeks and 3
months. However, questions 6,7,9 of the VCSS and 5,9 of the AVVQ
(stocking use, ulceration) failed to respond overall after 3 months. These
results may be of importance in deciding on future revisions of these
dynamic assessment tools.
ECG-Gated Dynamic Magnetic Resonance Is The Preferred Imaging
Modality For May-THurner Syndrome
C.A. Duran1, L. Abboud2, A.B. Lumsden1, D. Shah2, J. Bismuth1, 1The
Methodist DeBakey Heart and Vascular Institute, Houston, Tex, 2The
Methodist Hospital, Houston, Tex
Background: May-Thurner syndrome occurs secondary to chronic
extrinsic compression of the left common iliac vein by the overlying right
common iliac artery. Patients with symptoms consistent with this disease
merit further evaluation and treatment. Several options exist for noninvasive
diagnostic imaging. Ultrasound allows for rapid visualization of the lower
extremity vessels and is highly sensitive for detecting obstruction and reflux,
however it is a poor choice for visualizing the iliac vessels. CTA can identify
extrinsic sources of compression that is static but is limited in its ability to
identify dynamic compression that occurs only during a portion of the
cardiac cycle. Dynamic MR allows for noninvasive imaging of the pelvic
vasculature and surrounding structures with the ability to identify changes
that occur throughout the cardiac cycle. Here we present a series of 6
patients with suspected May-Thurners who underwent dynamic MR.
Methods: MR was performed using a 1.5-T or 3.0-T scanner (Mag-
netom Verio, Siemens Medical Solutions, Erlangen, Germany). Morpho-
logic images were obtained using ECG-gated bright blood steady state free
precession (6.0 mm slice) in axial, coronal and sagittal planes. ECG-gated
SSFP cine images (5.0 mm slice) were obtained in the axial plane at the level
of the aorto-iliac bifurcation (20-25 frames per cardiac cycle). High-
resolution 3D MR angiography (1.3 mm slice) was obtained in the coronal
plane during the administration of gadolinium-based contrast to obtain
arterial and venous phase images. ECG-gated, phase contrast images were
acquired to assess flow acceleration. After contrast administration, 2 addi-
tional steady state sequences are obtained; direct thrombus imaging se-
quence, and a postcontrast 3D gradient echo T1-weighted sequence in
which images comparable to CT are used to identify extrinsic compression,
poststenotic dilation, or superficial venous engorgement.
Results: Six patients presenting with symptoms of May-Thurners and
LLE venous reflux and varicocities by duplex U/S were evaluated with MR.
Criteria for diagnosis included: extrinsic compression or poststenotic dila-
tion, and demonstration of flow acceleration during systole. 3/6 had evi-
dence of May-Thurners by MR. Four patients (3 with MR, one negative
study but strong clinical suspicion), were evaluated with venography and
IVUS, confirming the diagnosis in all 3 patients with MR. One patient
with a negative MR had venous stenosis with luminal disease confirmed by
IVUS, without evidence of extrinsic compression by multiview venography.
Conclusion: Dynamic MR can diagnose May-Thurners by different
available sequences, and because these sequences are ECG-gated, can dem-
onstrate flow acceleration during systole, offering an important advantage
over CT, which only provides anatomical images. Limitation of MR is
demonstrated in the case where luminal disease was not identifiable.
Prospective Comparison of Iliac Vein Compression Using Computed
Tomography
R.J. Meisner, M. Gavalas, A. Tassiopoulos, A. Gasparis, N. Labropoulos,
Stonybrook University Hospital, Stony Brook, NY
Introduction: The anatomic course of the iliac veins as they travel
through pelvis has been implicated in venous disease. The true role in
contributing to venous disease is not exactly known but has gained more
attention as advanced imaging and endovascular tools are more available to
vascular physicians.
Methods:A prospective study of 30 consecutive asymptomatic patients
and 30 advanced venous disease patients were evaluated for proximal vein
compression. Contrast enhanced computerized tomography (CT) was used
to survey the common iliac veins through the pelvis as they interact with the
iliac arteries and the L5 vertebral body. Cross-sectional area of the maximally
compressed and uncompressed iliac veins was calculated using the major and
minor diameters of the vessel. Additional sites of external compression of the
caudal iliac veins at multiple levels were observed.
Results: The mean area reduction of the iliac veins were 36.65%/
20.23% for advanced venous disease patients, and 31.75% / 23.65% for
asymptomatic control patients. This difference was not statistically signifi-
cant with a p-value of 0.325 (Mann-Whitney U Test). In the advanced
venous disease patients, an area reduction of 25%, 50%, and 70% was seen
in 11, 7, and 2 patients, respectively. Equivalent area reductions were seen in
8, 7, and 1 asymptomatic control patient, respectively. In both groups there
were multiple sites of “alternative” compression or non-May-Thurner com-
pression found. In 18 patients (30%) we found this type of alternative
compression with the right common iliac vein being compressed by the right
common iliac artery (n  6) and the right common iliac vein being
compressed by the right internal iliac artery (n  6) as the most common.
Discussion:Despite the implicated role of extrinsic compression of the
iliac veins in venous disease, we did not find statistically significant area
reductions of the iliac veins in advanced venous disease patients as compared
with asymptomatic controls. Computed tomography, as a method to sys-
tematically quantify iliac vein compression has limitations. Even using mu-
litplanar reconstructions, measurement of the area of the iliac veins can be
difficult as the course of the vein is often not directly in the plane of the
image. It was noted that 30% of patients displayed “alternative” or non-May-
Thurner compression in their iliac vessels. The role of this alternative
compression in advanced venous disease patients is currently unknown.
Effect of Body Mass Index On Lower Extremity Duplex
Ultrasonography
J. Heller, Johns Hopkins, Baltimore, Md
Background: Duplex ultrasonography has long been considered the
gold standard diagnostic modality for evaluation of lower extremity acute
deep venous thrombosis. (DVT) Multiple known advantages include its
noninvasiveness, high sensitivity and specificity rates, and accuracy. How-
ever, certain clinical circumstances can negatively impact the findings of a
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duplex examination, such as body habitus. The purpose of this study was to
determine if there was a body mass index (BMI) cutoff at which duplex
ultrasonography was not an appropriate first test to rule out a DVT.
Methods: Sequential retrospective analysis was performed on all pa-
tients who underwent a lower extremity DVT examination in a single
ICAVL center.
Results: 496 patients were entered into the study for analysis. Gender,
age, BMI, and final impressions of the lower extremity venous duplex were
entered into the database for analysis. Patientswere categorized byBMI: patient
subgroups were divided in groups of BMIs of ranges of 10 points. There was a
direct correlation between increasing BMI and increasing proportion of incon-
clusive findings on examination.20: 17%, 20-25: 12%,25-30: 9%,30-40:
14%, 40-50: 26%, 50-60: 37%, 60-70: 86%, and 70: 50%. Using the
chi-squared test, these findings are significant p .0001.
Conclusions: Elevated BMI does carry with it an increased likelihood
of equivocal findings on duplex examination. These results suggest that
patients with BMI40 should consider undergoing an alternative diagnostic
imaging modality.
Predicting 60-Day Venous Thromboembolism Risk In Plastic and
Reconstructive Surgery Patients: A Comparison of the 2005 and 2010
Caprini Risk Assessment Models
P.R. Portschy1, C.J. Pannucci2, J. Barta1, G. Dreszer1, R.E. Hoxworth3,
L.K. Kalliainen1, E.G. Wilkins2, 1University of Minnesota, Minneapolis,
Minn, 2University of Michigan, Ann Arbor, Mich, 3University of Texas
Southwestern, Dallas, Tex
Background: The Caprini risk assessment model (RAM) is a weighted
risk stratification tool used to predict 30-day or 60-day venous thromboembo-
lism (VTE) risk. Compared to the 2005 model, the 2010 model has more
sub-categories and an additional risk factor. The 2010 RAM has not been
formally validated and the changes may alter a patient’s Caprini score and/or
the model’s ability to predict VTE risk. The Venous Thromboembolism Pre-
ventionStudy (VTEPS) is amulti-center surgery study examiningperi-operative
VTE risk factors and 60-day VTE outcomes in plastic surgery patients. The
study’s objective was to compare scores derived from the 2005 and 2010
Caprini RAM and examine their ability to predict 60-day VTE risk.
Methods: The VTEPS is a multicenter study previously described in
detail. The study utilized the 2005 Caprini RAM and assessed the incidence
of symptomatic VTE. We performed a matched observational cohort study
using the existing VTEPS database. Caprini scores using the 2005 and 2010
models were calculated and compared. Group differences in 2005 and 2010
Caprini scores were examined using the Wilcoxon Signed Rank test. De-
scriptive statistics that examined VTE incidence by stratified risk score were
generated. Differences in observed VTE rate, by stratified risk score, were
examined using Pearson’s chi-square test.
Results:When compared to 2005Caprini scores, 2010 scores were lower
in 17.6% of patients, unchanged in 23.3%, and higher in 59.2% (Fig 1). The
2010 Caprini scores increased the number of patients stratified as “super-high”
risk by three-fold. Patients classified as “super-high” risk (Caprini score 8)
using the 2005 Caprini RAM were significantly more likely to have a 60-day
VTE event when compared to patients classified as “super-high” risk using the
2010 guidelines (5.85% vs. 2.52%, P.021). There were no significant differ-
ences in observed 60-day VTE rate at any other risk level (Fig 2).
Conclusions: The 2005 version of the Caprini RAM is a validated risk
prediction tool for 60-day VTE events in adult plastic surgery patients who
require postoperative admission. We recommend that the 2005 Caprini RAM
be used to risk-stratify plastic surgery patients and guide prophylaxis decisions.
The 2010 Caprini RAM contains data-driven changes that may contribute to
improved risk stratification.However, themodel requires formal validationwith
appropriate determination of new risk levels prior to widespread adoption.
Non-Lipid-Lowering Effects of Rosuvastatin On Venous Thrombosis
in a Mouse Model of DVT
E. DeRoo, S.K. Wrobleski, A.E. Hawley, N.E. Ballard-Lipka, L. Brentin,
D.D. Myers, T.W. Wakefield, J.A. Diaz, University of Michigan, Ann
Arbor, Mich
Background: Inflammation is important throughout all stages of deep
vein thrombosis (DVT), especially in the onset of acute thrombogenesis.
Fibrinolysis, which is regulated by PAI-1, is essential for thrombus resolution.
Statins have been shown to possess pleiotropic properties that affect both
inflammation and the fibrinolytic system, independent of lowering lipids effect.
In the JUPITER trial, DVT was significantly decreased in nonhyperlipidemic
patients treated with rosuvastatin. However, the mechanism behind this effect
on DVT remains unclear. Here we investigated the anti-inflammatory and
pro-fibrinolytic properties of rosuvastatin using a mouse model of DVT.
Method: Inferior vena cava (IVC) ligation was performed to create a
DVT in C57BL/6 mice. This mouse strain is noninflammatory by nature.
Groups included: rosuvastatin treated (5mg/kg) and saline controls, start-
ing 2 days before surgery. IVCs and liver were harvested and blood samples
collected at very early time points (acute DVT) 3 hr, 6 hr and 2 days after
surgery. The IVC and its thrombus were evaluated for thrombus weight and
plasma samples for PAI-activity. In addition, gene expression of PAI-1 and
inflammatory markers (IL-6, CCL2, CRP, IL-1b, TNF) were measured in
vein wall (local effect) and liver (systemic effect).
Results: (Table). Thrombus weight was significantly decreased at day 2
post DVT in rosuvastatin mice, compared to controls, Vein wall PAI-1 gene
expression was significantly decreased at 3hr. Also, circulating active PAI-1
was significantly decreased at 6hr post DVT. IL-6 and CCL2 were signifi-
cantly decreased in vein wall at 3hr. Systemic IL-6, CRP and TNF were all
significantly decreased at 6 hours.
Conclusions:Rosuvastatin decreased inflammatorymarkers andPAI-1 in
this mouse model of DVT. An anti-inflammatory effect from rosuvastatin was
observed in the vein wall at 3hr, while a systemic effect was documented at 6hr
post thrombosis. A reduction in PAI-1 was observed both locally and systemi-
cally only in the rosuvastatin treated animals. These early anti-inflammatory and
pro-fibrinolytic effects, due to the administration of rosuvastatin, significantly
decreased thrombus weight 2 days post-IVC ligation, and suggest a potential
mechanism for rosuvastatin’s effect on DVT in the JUPITER trial.
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